Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Science Advances|September 17, 2019
Excited state intramolecular proton transfer in hydroxyanthraquinones: Toward predicting fading of organic red colorants in artJ A Berenbeim, S Boldissar, S Owens, et al.
The Journal of Infectious Diseases|January 8, 2008
A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patientsTheodora E M S de Vries-Sluijs, Bettina E Hansen, Gerard J J van Doornum, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 19, 2006
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patientsT E M S de Vries-Sluijs, A A van der Eijk, B E Hansen, et al.
Vaccine|January 1, 2013
Long-term response rates of successful hepatitis B vaccination in HIV-infected patientsVania Baptista Lopes, Robert J Hassing, Theodora E M S de Vries-Sluijs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2025
Impact of Socio-Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis BClémence Ramier, Anders Boyd, Colette Smit, et al.
AIDS (London, England)|February 1, 2019
Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rateJulian D Machiels, Esmée E Braam, Petra van Bentum, et al.
The Netherlands Journal of Medicine|December 9, 2017
Non-targeted HIV screening in emergency departments in the NetherlandsG P M Luiken, I K Joore, A Taselaar, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacementP D J Bollen, H A B Prins, A Colbers, et al.
The Journal of Infectious Diseases|January 27, 2011
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patientsTheodora E M S de Vries-Sluijs, Bettina E Hansen, Gerard J J van Doornum, et al.
Gastroenterology|August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virusTheodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Pageof 3